Abstract
The intravitreal injection of triamcinolone acelonide (TA) is widely used with or without vitrectomy for the treatment of macular edema. 1 - 4 However, there is a potential risk of developing postoperative endophthalmitisafter TA injection. Most recently, one case of bacterial endophthalmitis after TA-assisted vitrectomy has been reported in Japan. 1 Here, we present a second case of culture-proven bacterial endophthalmitis after TA-assisted vitrectomy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
